According to the research report titled ‘Europe Autoimmune Disease Diagnostics Market Size By Product, Localized Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 a?? 2026‘, available with Market Study Report, Europe autoimmune disease diagnostics market is anticipated to exceed a valuation of USD 5 billion by 2026.
 

High incidences of autoimmune disorders coupled with research initiatives taken by diagnostic institutes to comply with government standards, and surging healthcare expenditure are the major factors expected to drive Europe autoimmune disease diagnostics market during the forecast period.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609891/
 

As stated by National Institutes of Health (NIH), autoimmune diseases is major reason for increasing mortality rate among women. Furthermore, increasing acceptance of lab automation technology for benefits such as decrease in workload, improved turnaround time, surging number of tests is less time, and enhanced accuracy & reproducibility is likely to keep up autoimmune disease diagnostics market trend in Europe.
 

Rise in number of autoimmune diagnostic procedures is also expected to propel the demand for instruments and services for rapid and effective outcomes. However, insufficiency of skilled professionals in healthcare and slow diagnostic result turnaround are likely to hamper the growth of Europe autoimmune disease diagnostics market through 2026.
 

Based on product spectrum, systemic segment of Europe autoimmune disease diagnostics industry accounted for USD 1.6 billion in 2019. Antinuclear antibody test (ANA) is a major screening test used to identify the presence of autoantibodies and assess the patient for the specific autoimmune disease. Favorable government norms to create awareness regarding the diseases uplift the segmental growth.
 

Regionally, Germany autoimmune disease diagnostics market size is predicted to witness 1.6% growth rate during the forecast period, owing to increasing research & development activities in the region. Furthermore, surging cases of rheumatoid arthritis is creating huge burden on the government bodies; hence the German Society for Rheumatology is making efforts to handle the situation efficiently. Rising disease awareness and high prevalence of autoimmune diseases are estimated to propel autoimmune disease diagnostics market forecasts in Germany.
 

Key players operating in Europe autoimmune disease diagnostics industry are Abbott Laboratories, BioMerieux Inc., Crescendo Bioscience Inc., Bio-Rad Laboratories, Beckman Coulter Inc., Inova Diagnostics Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific Inc.